Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling
- PMID: 24284889
- DOI: 10.3892/or.2013.2872
Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling
Abstract
Activated hepatic stellate cells (HSCs) are the major subtype of stromal cells in the liver tumor microenvironment which can promote the growth and migration of hepatocellular carcinoma (HCC) cells. However, the underlying mechanisms by which activated HSCs exert their oncogenic effects are not fully understood to date. In the present study, we investigated the number of activated HSCs and its clinicopathological significance in HCC and uncovered its correlation with focal adhesion kinase (FAK)-MMP9 signaling. A higher number of activated HSCs was associated with tumor invasion of the portal vein, advanced TNM stage and poorer tumor differentiation. The number of activated HSCs was positively correlated with the expression levels of p-FAK and MMP9 in HCC. Furthermore, we studied the effects of activated HSCs on the migration and invasion of HCC cells in vitro. Conditioned medium (CM) from activated HSCs or co-culture with activated HSCs significantly induced the migration and invasion of HCC cells. In addition, activation of FAK-MMP9 signaling in HCC was demonstrated in the presence of activated HSC-CM and of co-culture. Inhibition of FAK-MMP9 signaling in HCC cells with FAK short hairpin RNA (shRNA) abrogated the effects of activated HSCs on HCC cells. Taken together, our data suggest that activated HSCs in the tumor microenvironment promote HCC cell migration and invasion via activation of FAK-MMP9 signaling.
Similar articles
-
Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis.Hepatology. 2011 Nov;54(5):1808-18. doi: 10.1002/hep.24562. Hepatology. 2011. PMID: 22045676
-
Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.Mol Pharm. 2011 Oct 3;8(5):1538-48. doi: 10.1021/mp200137c. Epub 2011 Aug 19. Mol Pharm. 2011. PMID: 21770423
-
3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.Oncotarget. 2015 Sep 15;6(27):23776-92. doi: 10.18632/oncotarget.4196. Oncotarget. 2015. PMID: 26068982 Free PMC article.
-
Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.Int J Cancer. 2020 Sep 15;147(6):1519-1527. doi: 10.1002/ijc.32899. Epub 2020 Mar 5. Int J Cancer. 2020. PMID: 32010970 Review.
-
Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.Liver Int. 2014 Jul;34(6):834-43. doi: 10.1111/liv.12465. Epub 2014 Feb 12. Liver Int. 2014. PMID: 24397349 Review.
Cited by
-
Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.J Transl Med. 2018 Nov 6;16(1):302. doi: 10.1186/s12967-018-1676-3. J Transl Med. 2018. PMID: 30400797 Free PMC article.
-
Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.Mol Med Rep. 2015 Jul;12(1):111-8. doi: 10.3892/mmr.2015.3429. Epub 2015 Mar 4. Mol Med Rep. 2015. PMID: 25738354 Free PMC article.
-
Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231163677. doi: 10.1177/15330338231163677. Technol Cancer Res Treat. 2023. PMID: 36938618 Free PMC article. Review.
-
Regulator of G-protein signaling-5 is a marker of hepatic stellate cells and expression mediates response to liver injury.PLoS One. 2014 Oct 7;9(10):e108505. doi: 10.1371/journal.pone.0108505. eCollection 2014. PLoS One. 2014. PMID: 25290689 Free PMC article.
-
Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma.PLoS Comput Biol. 2015 May 28;11(5):e1004293. doi: 10.1371/journal.pcbi.1004293. eCollection 2015 May. PLoS Comput Biol. 2015. PMID: 26020769 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous